Canada markets closed

Oncolytics Biotech Inc. (ONC.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
1.3000-0.0300 (-2.26%)
At close: 03:46PM EDT
Full screen
Previous Close1.3300
Open1.3500
Bid1.3100 x 0
Ask1.3200 x 0
Day's Range1.2500 - 1.3600
52 Week Range1.2000 - 3.1800
Volume57,945
Avg. Volume31,793
Market Cap99.914M
Beta (5Y Monthly)1.38
PE Ratio (TTM)N/A
EPS (TTM)-0.3800
Earnings DateNov 01, 2024 - Nov 05, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est6.65
  • Baystreet

    Stocks in play: Oncolytics Biotech Inc

    Announced that Chief Financial Officer Kirk Look will participate in a fireside chat at the H.C. Wainwright ...

  • PR Newswire

    Oncolytics Biotech® to Participate in Fireside Chats at Two Investment Conferences in September

    Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today announced that Chief Financial Officer Kirk Look will participate in a fireside chat at the H.C. Wainwright 26th Annual Global Investment Conference, which is taking place September 9-11, 2024 at the Lotte New York Palace Hotel in New York, NY. Chief Medical Officer Tom Heineman, M.D., Ph.D., will participate in a fireside chat at the 2024 Cantor Global Healthcar

  • GlobeNewswire

    Sernova Corp. Announces Appointment of New Chief Executive Officer

    LONDON, Ontario and BOSTON, Aug. 12, 2024 (GLOBE NEWSWIRE) -- August 12, 2024. Sernova Corp. (“Sernova” or the “Company”) (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage biotechnology company focused on the development of regenerative medicine cell therapies for treatment of chronic diseases, led by an ongoing phase 1/2a clinical trial in type 1 diabetes, is pleased to announce Mr. Jonathan Rigby as the Company’s new Chief Executive Officer. James Parsons, on behalf of the Board of Dir